prob with that line of thought is that while it looks attractive to use lani profilactically who will want it to last as long as possible without resistance ruining it's defensive potential against a more lethal strain - so logically they will recommend use for it that way only for the vulnerable and first liners/essential service persons. Either way it will still be a huge market - but can't see it taking over from vacc for the above reasons.
- Forums
- ASX - By Stock
- BTA
- goldman sachs: lani blockbuster-potential
goldman sachs: lani blockbuster-potential , page-6
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online